| |
 |
ARTICLES 
|
|
| Improved methodology for chemosensitivity testing? |
| SE Salmon |
|
JCO Dec 1 1987: 1861–1863.
[PDF]
|
 |
|
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study |
| |
Y Humblet, M Symann, A Bosly, L Delaunois, C Francis, J Machiels, M Beauduin, C Doyen, P Weynants, and J Longueville |
| |
JCO Dec 1 1987: 1864–1873.
[Abstract]
[PDF]
|
|
|
A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study |
| |
DJ Kwiatkowski, KJ Propert, RW Carey, N Choi, and M Green |
| |
JCO Dec 1 1987: 1874–1879.
[Abstract]
[PDF]
|
|
|
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial |
| |
M Wolf, K Havemann, R Holle, C Gropp, P Drings, K Hans, M Schroeder, M Heim, M Dommes, and S Mende |
| |
JCO Dec 1 1987: 1880–1889.
[Abstract]
[PDF]
|
|
|
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies |
| |
AA Epenetos, AJ Munro, S Stewart, R Rampling, HE Lambert, CG McKenzie, P Soutter, A Rahemtulla, G Hooker, and GB Sivolapenko |
| |
JCO Dec 1 1987: 1890–1899.
[Abstract]
[PDF]
|
|
|
Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin |
| |
CL Schwartz, CP Minniti, P Harwood, S Na, ML Banquerigo, LC Strauss, J Kurtzberg, SD Smith, and CI Civin |
| |
JCO Dec 1 1987: 1900–1911.
[Abstract]
[PDF]
|
|
|
Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system |
| |
JA Ajani, FL Baker, G Spitzer, A Kelly, W Brock, B Tomasovic, SE Singletary, M McMurtrey, and C Plager |
| |
JCO Dec 1 1987: 1912–1921.
[Abstract]
[PDF]
|
|
|
Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene |
| |
AT Fojo, DW Shen, LA Mickley, I Pastan, and MM Gottesman |
| |
JCO Dec 1 1987: 1922–1927.
[Abstract]
[PDF]
|
|
|
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug |
| |
DL Ahmann, DJ Schaid, HF Bisel, RG Hahn, JH Edmonson, and JN Ingle |
| |
JCO Dec 1 1987: 1928–1932.
[Abstract]
[PDF]
|
|
|
In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy |
| |
JH Phillips, BT Gemlo, WW Myers, AA Rayner, and LL Lanier |
| |
JCO Dec 1 1987: 1933–1941.
[Abstract]
[PDF]
|
|
|
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer |
| |
PB Chapman, TJ Lester, ES Casper, JL Gabrilove, GY Wong, SJ Kempin, PJ Gold, S Welt, RS Warren, and HF Starnes |
| |
JCO Dec 1 1987: 1942–1951.
[Abstract]
[PDF]
|
|
|
Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross- resistant regimen? |
| |
JL Bernard, T Philip, JM Zucker, D Frappaz, A Robert, G Margueritte, A Boilletot, N Philippe, P Lutz, and H Roche |
| |
JCO Dec 1 1987: 1952–1959.
[Abstract]
[PDF]
|
|
|
The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia |
| |
HS Chan, Z Estrov, SS Weitzman, and MH Freedman |
| |
JCO Dec 1 1987: 1960–1967.
[Abstract]
[PDF]
|
|
|
A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients |
| |
NJ Vogelzang, M Ruane, MJ Ratain, K Dhowlatshahi, and GW Chodak |
| |
JCO Dec 1 1987: 1968–1976.
[Abstract]
[PDF]
|
|
|
Effects of socioeconomic and clinical factors on survival in multiple myeloma |
| |
B Weston, S Grufferman, JP MacMillan, and HJ Cohen |
| |
JCO Dec 1 1987: 1977–1984.
[Abstract]
[PDF]
|
|
|
Favorable outcome of invasive aspergillosis in patients with acute leukemia |
| |
PA Burch, JE Karp, WG Merz, JE Kuhlman, and EK Fishman |
| |
JCO Dec 1 1987: 1985–1993.
[Abstract]
[PDF]
|
|
|
A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen |
| |
BR Meyer, V O'Mara, and MM Reidenberg |
| |
JCO Dec 1 1987: 1994–1997.
[Abstract]
[PDF]
|
|
|
Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications |
| |
S Nand, SG Fisher, R Salgia, and RI Fisher |
| |
JCO Dec 1 1987: 1998–2003.
[Abstract]
[PDF]
|
|
|
Appropriate endpoints for superficial bladder cancer clinical trials |
| |
LA Kalish, MB Garnick, and JP Richie |
| |
JCO Dec 1 1987: 2004–2008.
[Abstract]
[PDF]
|
|
|
The pharmacology of intraperitoneally administered bleomycin |
| |
SB Howell, M Schiefer, PA Andrews, M Markman, and I Abramson |
| |
JCO Dec 1 1987: 2009–2016.
[Abstract]
[PDF]
|
|
|
High-dose methotrexate: a critical reappraisal |
| |
SP Ackland and RL Schilsky |
| |
JCO Dec 1 1987: 2017–2031.
[Abstract]
[PDF]
|
|
|
Trimetrexate: a second generation folate antagonist in clinical trial |
| |
JT Lin and JR Bertino |
| |
JCO Dec 1 1987: 2032–2040.
[Abstract]
[PDF]
|
|
| Whither carboplatin? A replacement for or an alternative to cisplatin? |
| A Gil |
|
JCO Dec 1 1987: 2041a–2042.
[PDF]
|
|
| Preventing amsacrine-induced cardiac arrhythmias |
| EJ Feldman, ZA Arlin, P Sullivan, and C Engelking |
|
JCO Dec 1 1987: 2041b.
[PDF]
|
|
| Three-way reciprocal chromosomal translocation in an acute lymphoblastic leukemia patient with hypereosinophilia syndrome |
| TS McConnell, K Foucar, WR Hardy, and J Saiki |
|
JCO Dec 1 1987: 2042–2044.
[PDF]
|
|
| Hypofibrinogenemia and acute lymphoblastic leukemia |
| A Van Hoof, A Louwagie, and A Criel |
|
JCO Dec 1 1987: 2044.
[PDF]
|
|
